Cartesian Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Cartesian Therapeutics has a total shareholder equity of $752.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $455.3M and $454.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$219.20m |
| Equity | US$752.00k |
| Total liabilities | US$454.56m |
| Total assets | US$455.32m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1S70's short term assets ($229.1M) exceed its short term liabilities ($21.4M).
Long Term Liabilities: 1S70's short term assets ($229.1M) do not cover its long term liabilities ($433.2M).
Debt to Equity History and Analysis
Debt Level: 1S70 is debt free.
Reducing Debt: 1S70 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1S70 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 1S70 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 2.5% each year